3D ED for biomolecules: vitamin B2.
How riboflavin was solved from sub-micron needles – with absolute configuration.
What you'll learn
- How 3D ED solves biomolecules available only in tiny, impure amounts
- How riboflavin was determined from sub-micron needles
- How ED delivers absolute configuration with dedicated-instrument data quality
Why it matters
Biomolecules often occur in low concentration and impure form, leaving too little material to grow crystals for single-crystal X-ray diffraction. This note shows how 3D ED solved riboflavin (vitamin B2) from sub-micron needles, delivering dedicated-instrument data quality and absolute configuration.
At a glance: 3D ED / MicroED · riboflavin (vitamin B2) · sub-micron needles · absolute configuration · dedicated-instrument data quality.
Book a meeting with our team →Download the application note
After submitting the form, you'll receive an email with a link to download the application note (PDF).
ELDICO Scientific AG, "The Electron Diffraction Company," stands at the forefront of Swiss technology and innovation. Established in 2019, ELDICO is dedicated to advancing scientific exploration with its groundbreaking electron diffractometer. This pioneering device empowers researchers to unravel the mysteries of the nanoscale world, providing precise answers to their inquiries. Through the development, production, and sale of this cutting-edge technology, ELDICO is shaping the future of particle analysis and driving progress in scientific discovery.
In 2022, ELDICO Scientific opened its Experience Centre for electron diffraction in Basel, Switzerland, showcasing its cutting-edge device, the ELDICO ED-1. Nestled within the Switzerland Innovation Park Basel, this center provides an exclusive platform for customers to delve into the world of electron diffraction. Here, they can access a range of services, including contract research, scientific application development, collaborative opportunities, and tailored training workshops. Our clientele primarily comprises researchers from industrial and R&D-intensive sectors, particularly in burgeoning fields such as pharmaceuticals, energy storage, and advanced materials.